Literature DB >> 15592997

Etiologies and manifestations of persistent diarrhea in adults with HIV-1 infection: a case-control study in Lima, Peru.

César Cárcamo1, Thomas Hooton, Mark H Wener, Noel S Weiss, Robert Gilman, Jorge Arevalo, Juan Carrasco, Carlos Seas, Martin Caballero, King K Holmes.   

Abstract

UNLABELLED: OBJECTIVE We sought to determine the etiologies, manifestations, and risk factors for persistent (> or =7 days) diarrhea in human immunodeficiency virus type 1 (HIV-1)-infected persons in Peru.
DESIGN: The present study is a case-control study of 147 HIV-1-infected case subjects with persistent diarrhea and 147 HIV-1-infected control subjects without diarrhea.
METHODS: We obtained clinical, demographic, and exposure data, CD4 lymphocyte counts, and stool samples for detection of enteric parasitic and bacterial pathogens and rotavirus.
RESULTS: One or more enteric pathogen was identified in 55% of case subjects and 21% of control subjects (odds ratio adjusted for CD4 lymphocyte count, 3.8; 95% confidence interval, 2.2-6.5). The median CD4 lymphocyte count was highest with pathogen-free diarrhea and lowest with Cryptosporidium infection. Cryptosporidium species (the most frequent pathogen), Giardia lamblia, Aeromonas species, Campylobacter species, and rotavirus were all significantly associated with diarrhea. Bacterial pathogens were significantly associated with G. lamblia and rotavirus infection. Of the bacterial pathogens (Aeromonas, Campylobacter, Salmonella, and Vibrio species and enterotoxigenic Escherichia coli), only 24% were susceptible to cotrimoxazole, whereas 90% were susceptible to ciprofloxacin. In no case did the sensitivity or positive predictive value of specific clinical and laboratory findings for curable enteric infections exceed 50%.
CONCLUSIONS: Several enteric pathogens were associated with diarrhea in HIV-1-infected case subjects in Peru, especially among those who were heterosexual. Clinical findings were poor predictors of detectable microbial etiology. The guidelines for initial management of chronic diarrhea with sulfamethoxazole-trimethoprim in HIV-1-infected persons require revision, at least in settings where prophylaxis with this agent is common.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15592997     DOI: 10.1086/426508

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  AIDS diarrhea and antiretroviral drug concentrations: a matched-pair cohort study in Port au Prince, Haiti.

Authors:  Rebecca Dillingham; Paul Leger; Carole-Anne Beauharnais; Erica Miller; Angela Kashuba; Steven Jennings; Kathryn Dupnik; Amidou Samie; Etna Eyma; Richard Guerrant; Jean Pape; Daniel Fitzgerald
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  Postmortem findings and opportunistic infections in HIV-positive patients from a public hospital in Peru.

Authors:  Dominique Eza; Gustavo Cerrillo; David A J Moore; Cecilia Castro; Eduardo Ticona; Domingo Morales; Jose Cabanillas; Fernando Barrantes; Alejandro Alfaro; Alejandro Benavides; Arturo Rafael; Gilberto Valladares; Fernando Arevalo; Carlton A Evans; Robert H Gilman
Journal:  Pathol Res Pract       Date:  2006-09-19       Impact factor: 3.250

3.  Diarrheagenic Escherichia coli in human immunodeficiency virus (HIV) pediatric patients in Lima, Peru.

Authors:  Anicia M Medina; Fulton P Rivera; Liliana M Romero; Lenka A Kolevic; Maria E Castillo; Eduardo Verne; Roger Hernandez; Yovanna E Mayor; Francesca Barletta; Erik Mercado; Theresa J Ochoa
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

4.  Rotavirus infection and epidermal necrolysis of the bowel in a patient with AIDS.

Authors:  Joshua Tisdell Schiffer; Janice Leung
Journal:  BMJ Case Rep       Date:  2009-11-29

5.  High frequency of diarrheagenic Escherichia coli in human immunodeficiency virus (HIV) patients with and without diarrhea in Lima, Peru.

Authors:  Coralith Garcia; Omayra Chincha; Mey Leon; David Iglesias; Francesca Barletta; Erik Mercado; Theresa Ochoa
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

Review 6.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

7.  Secondary syphilis in cali, Colombia: new concepts in disease pathogenesis.

Authors:  Adriana R Cruz; Allan Pillay; Ana V Zuluaga; Lady G Ramirez; Jorge E Duque; Gloria E Aristizabal; Mary D Fiel-Gan; Roberto Jaramillo; Rodolfo Trujillo; Carlos Valencia; Linda Jagodzinski; David L Cox; Justin D Radolf; Juan C Salazar
Journal:  PLoS Negl Trop Dis       Date:  2010-05-18

Review 8.  Clinical significance of enteric protozoa in the immunosuppressed human population.

Authors:  D Stark; J L N Barratt; S van Hal; D Marriott; J Harkness; J T Ellis
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

9.  High early mortality in patients with chronic acquired immunodeficiency syndrome diarrhea initiating antiretroviral therapy in Haiti: a case-control study.

Authors:  Rebecca A Dillingham; Relana Pinkerton; Paul Leger; Patrice Severe; Richard L Guerrant; J William Pape; Daniel W Fitzgerald
Journal:  Am J Trop Med Hyg       Date:  2009-06       Impact factor: 2.345

10.  Enteric Pathogens in HIV/AIDS from a Tertiary Care Hospital.

Authors:  Beena Uppal; Bineeta Kashyap; Preena Bhalla
Journal:  Indian J Community Med       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.